株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アレルギー診断の世界市場 〜2022年:診断キット、免疫学的測定法 & ELIZA分析装置、ルミノメーター、サービス

Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 321266
出版日 ページ情報 英文 151 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.66円で換算しております。
Back to Top
アレルギー診断の世界市場 〜2022年:診断キット、免疫学的測定法 & ELIZA分析装置、ルミノメーター、サービス Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) - Global Forecast to 2022
出版日: 2017年08月31日 ページ情報: 英文 151 Pages
概要

アレルギー診断の世界市場は、2017年から2022年にかけて10.5%の複合年間成長率(CAGR)で57億4000万米ドル規模に拡大することが予測されています。市場成長の主な促進要因として、アレルギー疾患患者の増加のほか、環境汚染の拡大、医療費の増大、米国の医療保険制度改革などが挙げられます。製品別に見ると、アッセイキットが今後急速に成長する見通しです。

当レポートでは、アレルギー診断の世界市場に注目し、製品・サービス、アレルゲン (アレルギー誘発物質)、検査方法、エンドユーザー、地域の別にその推移を予測するほか、市場の現況、発展への影響要因、競合環境、有力企業などについて最新の調査・分析情報をまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主要考察

  • アレルギー診断市場の概要
  • アレルギー診断市場:アレルゲン別
  • アレルギー診断市場の地域概要
  • アレルギー診断市場:検査タイプ別

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 推進要因
      • アレルギー疾患の発症率の高さと経済的負担の重さ
      • 環境汚染の拡大
      • 医療費拡大
    • 阻害要因
      • 小規模診な診断所および診療所にとって高額な設備機器
      • アレルギー疾患に対する認知度の低さ
    • 機会
      • アジア太平洋およびその他の地域(RoW)の成長機会
    • 動向
      • オートメーションの導入による診断時間の短縮
      • 検査試薬レンタル契約の登場

第6章 アレルギー診断市場:製品 & サービス別

  • イントロダクション
  • 診断キット
  • 診断装置
  • 免疫測定分析装置
    • ルミノメーター (照度計)
    • ELISA (酵素結合免疫吸着法) 分析装置
    • その他
  • サービス

第7章 アレルギー診断市場:検査法別

  • イントロダクション
  • 生体内 (in vivo) 検査
  • 体外 (in vitro) 検査

第8章 アレルギー診断市場:アレルゲン別

  • イントロダクション
  • 吸入アレルゲン
  • 食品アレルゲン
  • 薬物アレルゲン
  • その他のアレルゲン

第9章 アレルギー診断市場:エンドユーザー別

  • イントロダクション
  • 診断試験所
  • 病院
  • 学術研究機関
  • その他

第10章 アレルギー診断市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州諸国
  • アジア
    • 中国
    • 日本
    • インド
    • その他アジア諸国
  • その他の地域 (ROW)
    • ラテンアメリカ
    • 太平洋・オセアニア
    • 中東・アフリカ

第11章 競合環境

  • イントロダクション
  • 市場シェアの分析
  • リーダーシップマッピング
  • 競合ベンチマーキング

第12章 企業プロファイル

  • イントロダクション
  • THERMO FISHER SCIENTIFIC INC.
  • SIEMENS AG
  • DANAHER CORPORATION
  • OMEGA DIAGNOSTICS GROUP PLC
  • 日立化成
  • BIOMERIEUX SA
  • STALLERGENES GREER
  • HOB BIOTECH GROUP SUZHOU CO., LTD.
  • HYCOR BIOMEDICAL, INC.
  • LINCOLN DIAGNOSTICS, INC.
  • R-BIOPHARM AG

第13章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 2955

The global allergy diagnostics market is expected to reach USD 5.74 billion by 2022, at a CAGR of 10.5% from 2017 to 2022. The major factors driving this market are the high incidence and large economic burden of allergic diseases, rising environmental pollution levels, increasing healthcare expenditure, and growing access to medical insurance in the US. On the other hand, the growth of this market is hindered to some extent due to the limited awareness about allergy diagnosis in some developing countries.

Assay kits to register the highest CAGR during the forecast period

The allergy diagnostics market is classified on the basis of product & service into assay kits, instruments, and services. The assay kits segment is expected to grow at the highest rate during the forecast period. The widespread availability and large consumption of assay kits in allergy testing are expected to drive the growth of this segment in the coming years.

Diagnostic laboratories to dominate the allergy diagnostics market during the forecast period

The allergy diagnosis market is segmented based on end users into diagnostic laboratories, hospital-based laboratories, academic & research institutes, and other end users. In 2017, the diagnostic laboratories segment is expected to command the largest share and is estimated to grow at the fastest rate as compared to other segments. The market is mainly driven by the increasing incidence of allergic disorders in emerging countries.

Asia is estimated to be the fastest growing regional segment in the market during the forecast period

Geographically, the allergy diagnostics market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The Asian region is estimated to grow at the fastest rate which can be attributed to the improving life sciences research infrastructure in emerging economies and rising investments by governments to promote research activities.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 70% and Tier 2 - 30%
  • By Designation - C-level - 62%, Director Level - 21%, Others - 17%
  • By Region - North America - 20%, Europe - 30%, Asia - 50%

The key players in the market are Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd. (Japan), bioMerieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE - Achterrath Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), Tecan Trading AG (Switzerland), DST Diagnostische Systeme & Technologien GmbH (Germany), ROXALL Medical GmbH (Germany), ALK-Abello A/S (Denmark), Angsana Molecular & Diagnostics Laboratory Pte Ltd. (Singapore), Allergy Therapeutics (UK), Astra Biotech GmbH (Germany), HAL Allergy Group (Netherlands), Theradiag (France), and Demeditec Diagnostics GmbH (Germany).

Study Coverage:

The report analyses the allergy diagnostics market by product and service, test, allergen, end user, and region. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the type, products, test, end users, and regions.

Key Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the allergy diagnostics market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the allergy diagnostics market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the allergy diagnostics market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various allergy diagnostic products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the allergy diagnostics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Primary sources
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ALLERGY DIAGNOSTICS: MARKET OVERVIEW
  • 4.2. ALLERGY DIAGNOSTICS MARKET, BY ALLERGENS (2017)
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE ALLERGY DIAGNOSTICS MARKET
  • 4.4. ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2017 VS. 2022

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. High incidence and large economic burden of allergic diseases
      • 5.2.1.2. Rising environmental pollution levels
      • 5.2.1.3. Increasing healthcare expenditure
      • 5.2.1.4. Increasing access for allergy diagnosis medical insurance in the US
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Issues related to the affordability of allergy diagnostics instruments among small laboratories and physician clinics
      • 5.2.2.2. Low awareness of allergic diseases
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging economies across Asia and RoW
    • 5.2.4. TRENDS
      • 5.2.4.1. Growing adoption of automation for quicker turnaround times
      • 5.2.4.2. Growth in the number of reagent rental agreements

6. ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE

  • 6.1. INTRODUCTION
  • 6.2. ASSAY KITS
  • 6.3. INSTRUMENTS
    • 6.3.1. IMMUNOASSAY ANALYZERS
    • 6.3.2. LUMINOMETERS
    • 6.3.3. ELISA ANALYZERS
    • 6.3.4. OTHER INSTRUMENTS
  • 6.4. SERVICES

7. ALLERGY DIAGNOSTICS MARKET, BY TEST

  • 7.1. INTRODUCTION
  • 7.2. IN VIVO TESTS
  • 7.3. IN VITRO TESTS

8. ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN

  • 8.1. INTRODUCTION
  • 8.2. INHALED ALLERGENS
  • 8.3. FOOD ALLERGENS
  • 8.4. DRUG ALLERGENS
  • 8.5. OTHER ALLERGENS

9. ALLERGY DIAGNOSTICS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. DIAGNOSTIC LABORATORIES
  • 9.3. HOSPITAL-BASED LABORATORIES
  • 9.4. ACADEMIC RESEARCH INSTITUTES
  • 9.5. OTHER END USERS

10. ALLERGY DIAGNOSTICS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. UK
    • 10.3.3. FRANCE
    • 10.3.4. ITALY
    • 10.3.5. SPAIN
    • 10.3.6. REST OF EUROPE (ROE)
  • 10.4. ASIA
    • 10.4.1. CHINA
    • 10.4.2. JAPAN
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA (ROA)
  • 10.5. REST OF THE WORLD
    • 10.5.1. LATIN AMERICA
    • 10.5.2. PACIFIC AND OCEANIA
    • 10.5.3. MIDDLE EAST AND AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE LEADERSHIP MAPPING
    • 11.3.1. VISIONARY LEADERS
    • 11.3.2. INNOVATORS
    • 11.3.3. DYNAMIC DIFFERENTIATORS
    • 11.3.4. EMERGING COMPANIES
  • 11.4. COMPETITIVE BENCHMARKING
    • 11.4.1. STRENGTH OF PRODUCT PORTFOLIO (25 PLAYERS)
    • 11.4.2. BUSINESS STRATEGY EXCELLENCE (25 PLAYERS)

Top 25 companies analysed for this study are - Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd (Japan), bioMerieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE - Achterrath Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), Tecan Trading AG (Switzerland), DST Diagnostische Systeme & Technologien GmbH (Germany), ROXALL Medical GmbH (Germany), ALK-Abello A/S (Denmark), Angsana Molecular & Diagnostics Laboratory Pte Ltd, Allergy Therapeutics (UK), Astra Biotech GmbH (Germany), HAL Allergy Group (Netherlands), Theradiag (France), Demeditec Diagnostics GmbH (Germany)

12. COMPANY PROFILES (Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development's, Business Strategy)*

  • 12.1. THERMO FISHER SCIENTIFIC INC.
  • 12.2. SIEMENS AG
  • 12.3. DANAHER CORPORATION
  • 12.4. OMEGA DIAGNOSTICS GROUP PLC
  • 12.5. HITACHI CHEMICAL CO., LTD.
  • 12.6. BIOMERIEUX SA
  • 12.7. STALLERGENES GREER
  • 12.8. HOB BIOTECH GROUP SUZHOU CO., LTD.
  • 12.9. HYCOR BIOMEDICAL, INC.
  • 12.10. LINCOLN DIAGNOSTICS, INC.
  • 12.11. R-BIOPHARM AG

*Details on Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development's, Business Strategy might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: ALLERGY DIAGNOSTICS MARKET SUMMARY
  • TABLE 2: HEALTHCARE EXPENDITURE, BY COUNTRY, 2005-2014 (USD BILLION)
  • TABLE 3: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 4: ALLERGY DIAGNOSTICS ASSAY KITS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 6: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET FOR IMMUNOASSAY ANALYZERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET FOR LUMINOMETERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET FOR ELISA ANALYZERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: OTHER ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: ALLERGY DIAGNOSTICS SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 13: IN VIVO ALLERGY TESTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: IN VITRO ALLERGY TESTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 16: INHALED ALLERGENS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: FOOD ALLERGENS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: DRUG ALLERGENS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: OTHER ALLERGENS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 21: ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: ALLERGY DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 27: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 28: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 29: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 30: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 31: US: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 32: US: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 33: US: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 34: US: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 35: CANADA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 36: CANADA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 37: CANADA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 38: CANADA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 39: EUROPE: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 40: EUROPE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 41: EUROPE: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 42: EUROPE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 43: EUROPE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 44: GERMANY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 45: GERMANY: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 46: GERMANY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 47: GERMANY: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 48: UK: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 49: UK: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 50: UK: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 51: UK: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 52: FRANCE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 53: FRANCE: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 54: FRANCE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 55: FRANCE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 56: ITALY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 57: ITALY: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 58: ITALY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 59: ITALY: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 60: SPAIN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 61: SPAIN: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 62: SPAIN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 63: SPAIN: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 64: ROE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 65: ROE: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 66: ROE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 67: ROE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 68: ASIA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 69: ASIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 70: ASIA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 71: ASIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 72: ASIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 73: CHINA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 74: CHINA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 75: CHINA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 76: CHINA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 77: JAPAN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 78: JAPAN: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 79: JAPAN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 80: JAPAN: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 81: INDIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 82: INDIA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 83: INDIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 84: INDIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 85: ROA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 86: ROA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 87: ROA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 88: ROA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 89: ROW: ALLERGY DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 90: ROW: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 91: ROW: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 92: ROW: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 93: ROW: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 94: LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 95: LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 96: LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 97: LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 98: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 99: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 100: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 101: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 102: MIDDLE EAST AND AFRICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 103: MIDDLE EAST AND AFRICA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 104: MIDDLE EAST AND AFRICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 105: MIDDLE EAST AND AFRICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL ALLERGY DIAGNOSTICS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: ALLERGY DIAGNOSTICS MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: ALLERGY DIAGNOSTICS MARKET: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION
  • FIGURE 7: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017 VS. 2022 (USD BILLION)
  • FIGURE 8: ALLERGY DIAGNOSTICS MARKET, BY ALLERGENS, 2017 VS. 2022 (USD BILLION)
  • FIGURE 9: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2017 VS. 2022 (USD BILLION)
  • FIGURE 10: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2017 VS. 2022 (USD BILLION)
  • FIGURE 11: ALLERGY DIAGNOSTICS MARKET, BY REGION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 12: HIGH INCIDENCE AND LARGE ECONOMIC BURDEN OF ALLERGIC DISEASES IS EXPECTED TO DRIVE THE MARKET
  • FIGURE 13: INHALED ALLERGENS SEGMENT TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET IN 2017
  • FIGURE 14: ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 15: IN VIVO TESTS TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET DURING 2017 TO 2022
  • FIGURE 16: ALLERGY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
  • FIGURE 17: ASSAY KITS TO FORM THE LARGEST PRODUCT SEGMENT IN 2017
  • FIGURE 18: IN VIVO TESTS SEGMENT TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET DURING 2017-2022
  • FIGURE 19: INHALED ALLERGENS SEGMENT TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET IN 2017
  • FIGURE 20: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 21: NORTH AMERICA TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET IN 2017
  • FIGURE 22: NORTH AMERICA: ALLERGY DIAGNOSIS MARKET SNAPSHOT
  • FIGURE 23: ASIA: ALLERGY DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 24: GLOBAL ALLERGY DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
  • FIGURE 25: ALLERGY DIAGNOSTICS MARKET (GLOBAL): COMPETITIVE LEADERSHIP MAPPING, 2017
  • FIGURE 26: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 27: SIEMENS AG: COMPANY SNAPSHOT (2016)
  • FIGURE 28: DANAHER CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 29: OMEGA DIAGNOSTICS GROUP PLC: COMPANY SNAPSHOT (2016)
  • FIGURE 30: HITACHI CHEMICAL CO., LTD.: COMPANY SNAPSHOT (2016)
  • FIGURE 31: BIOMERIEUX SA: COMPANY SNAPSHOT (2016)
  • FIGURE 32: STALLERGENES GREER: COMPANY SNAPSHOT (2016)
Back to Top